-
1 .
Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial
- 저자
- by Markus P Schlaich; Marc Bellet; Michael A Weber; Parisa Danaietash; George L Bakris, et al.
- 소스
- The Lancet (London), 400, 1927-1937
The Lancet, 400(10367), 1927-1937. Elsevier Limited
The Lancet (London), 400, 10367, pp. 1927-1937